| Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis (NCT03533972) | Tatyasaheb Kore Dental College | 2017-11-30 |
| Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI (NCT03373409) | Concentrx Pharmaceuticals, Inc. | 2017-11-30 |
| Mix Vaccine for Metastatic Sarcoma Patients (NCT03357315) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Mix Vaccine for Metastatic Colorectal Cancer (NCT03357276) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382 (NCT03341013) | MedImmune LLC | 2017-11-30 |
| Mix Vaccine for Metastatic Kidney Cancer (NCT03357289) | Fuda Cancer Hospital, Guangzhou | 2017-11-30 |
| Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation (NCT03072589) | Christine Lau, MD | 2017-11-30 |
| BAY94-9027 PK Study Comparing to Another Long Acting Product (NCT03364998) | Bayer | 2017-11-30 |
| Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy (NCT03353402) | Sheba Medical Center | 2017-11-30 |
| Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration (NCT03324061) | Eagle Pharmaceuticals, Inc. | 2017-11-30 |
| Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2). (NCT03370640) | Sumitomo Pharma Co., Ltd. | 2017-11-29 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age (NCT03303625) | Janssen Vaccines & Prevention B.V. | 2017-11-29 |
| PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma (NCT03269136) | Pfizer | 2017-11-29 |
| Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) (NCT03277638) | Case Comprehensive Cancer Center | 2017-11-29 |
| Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer (NCT03379428) | US Oncology Research | 2017-11-29 |
| Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma (NCT03338972) | Fred Hutchinson Cancer Center | 2017-11-29 |
| Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma (NCT03123276) | Royal Marsden NHS Foundation Trust | 2017-11-29 |
| Survival Prolongation by Rationale Innovative Genomics (NCT03386929) | Worldwide Innovative Network Association | 2017-11-29 |
| Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam (NCT03353857) | Bayer | 2017-11-29 |
| Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) (NCT03320525) | Herlev Hospital | 2017-11-29 |
| Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy (NCT03611426) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2017-11-29 |
| Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis (NCT03310320) | AstraZeneca | 2017-11-29 |
| A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia (NCT03399084) | Sandoz | 2017-11-29 |
| A Study of Single-dose ALXN2050 in Healthy Adults (NCT05047458) | Alexion Pharmaceuticals, Inc. | 2017-11-28 |
| Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge (NCT03416036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-11-28 |
| Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency (NCT02168686) | Adverum Biotechnologies, Inc. | 2017-11-28 |
| A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors (NCT03386942) | Eisai Inc. | 2017-11-28 |
| Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer (NCT03386500) | University of Nebraska | 2017-11-28 |
| Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day (NCT04585321) | Fidia Farmaceutici s.p.a. | 2017-11-28 |
| First-in-human Study of VE303 in Healthy Adult Volunteers (NCT04236778) | Vedanta Biosciences, Inc. | 2017-11-28 |
| Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment (NCT03423446) | Lexicon Pharmaceuticals | 2017-11-28 |
| A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver (NCT03357380) | Novo Nordisk A/S | 2017-11-28 |
| Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors (NCT03364400) | Vigeo Therapeutics, Inc. | 2017-11-28 |
| Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants (NCT03381664) | Avanir Pharmaceuticals | 2017-11-28 |
| Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S (NCT03615911) | Marylyn Addo | 2017-11-28 |
| Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD (NCT03335852) | Allergan | 2017-11-28 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes (NCT03406585) | NextCell Pharma Ab | 2017-11-28 |
| Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL) (NCT03298893) | Institut Curie | 2017-11-27 |
| Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer (NCT03054363) | University of Colorado, Denver | 2017-11-27 |
| Relative Bioavailability (RBA) Study of LY03005 vs Pristiq® (NCT03357796) | Luye Pharma Group Ltd. | 2017-11-27 |
| Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a) (NCT03614715) | Cinnagen | 2017-11-27 |
| Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects (NCT03369002) | Gilead Sciences | 2017-11-27 |
| Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia (NCT03333005) | Basilea Pharmaceutica | 2017-11-27 |
| Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects. (NCT03366688) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-11-27 |
| Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects (NCT03363984) | Idorsia Pharmaceuticals Ltd. | 2017-11-27 |
| An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer (NCT03351231) | Bristol-Myers Squibb | 2017-11-27 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456 (NCT03282851) | Fresenius Kabi SwissBioSim GmbH | 2017-11-27 |
| Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors (NCT03379259) | BeiGene | 2017-11-27 |
| A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma (NCT03181126) | AbbVie | 2017-11-27 |
| A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors (NCT03362723) | Hoffmann-La Roche | 2017-11-27 |
| Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle (NCT03079401) | Boston Children's Hospital | 2017-11-27 |
| Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (NCT03331198) | Juno Therapeutics, a Subsidiary of Celgene | 2017-11-27 |
| Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382 (NCT03347968) | MedImmune LLC | 2017-11-27 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers (NCT03356561) | Janssen Vaccines & Prevention B.V. | 2017-11-26 |
| Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) (NCT04264546) | Jiangsu Province Centers for Disease Control and Prevention | 2017-11-24 |
| A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects (NCT03352726) | DBV Technologies | 2017-11-24 |
| Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers (NCT04863105) | The Affiliated Hospital of Qingdao University | 2017-11-24 |
| A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer (NCT03332797) | Genentech, Inc. | 2017-11-24 |
| Drug-drug Interaction Between Simvastatin and SHR3824 (NCT03329118) | Jiangsu HengRui Medicine Co., Ltd. | 2017-11-24 |
| A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid Tumors (NCT03316638) | Pierre Fabre Medicament | 2017-11-24 |
| Plasmodium Immunotherapy for Advanced Cancers (NCT03375983) | CAS Lamvac Biotech Co., Ltd. | 2017-11-23 |
| This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men (NCT03349723) | Boehringer Ingelheim | 2017-11-23 |
| Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varlitinib (NCT03368846) | ASLAN Pharmaceuticals | 2017-11-23 |
| A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma (NCT03307746) | University Hospital Southampton NHS Foundation Trust | 2017-11-23 |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases (NCT03093909) | M.D. Anderson Cancer Center | 2017-11-22 |
| Tolerance and Pharmacokinetics of TQ-B3233 (NCT03453034) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-11-22 |
| A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants (NCT03316976) | Takeda | 2017-11-22 |
| Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy (NCT03234491) | Yale University | 2017-11-22 |
| A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects (NCT03346837) | Bristol-Myers Squibb | 2017-11-22 |
| Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study (NCT03478020) | Aquinox Pharmaceuticals (Canada) Inc. | 2017-11-22 |
| Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patients (NCT03341988) | Assiut University | 2017-11-22 |
| A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors (NCT03314935) | Incyte Corporation | 2017-11-21 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans" (NCT03267784) | RHEACELL GmbH & Co. KG | 2017-11-21 |
| Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750 (NCT03346330) | Toray Industries, Inc | 2017-11-21 |
| Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder (NCT03317158) | Noah Hahn, M.D. | 2017-11-21 |
| APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies (NCT03386526) | Ascentage Pharma Group Inc. | 2017-11-21 |
| Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers (NCT03372239) | NewLink Genetics Corporation | 2017-11-21 |
| A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954 (NCT03296787) | Takeda | 2017-11-21 |
| Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT03121989) | Sunnybrook Health Sciences Centre | 2017-11-21 |
| Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy (NCT02998736) | Ottawa Hospital Research Institute | 2017-11-21 |
| Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults (NCT03342963) | Otsuka Pharmaceutical Co., Ltd. | 2017-11-21 |
| INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (NCT03277352) | Incyte Biosciences International Sàrl | 2017-11-21 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults (NCT03357263) | Green Cross Corporation | 2017-11-20 |
| Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia (NCT03781115) | University of Arizona | 2017-11-20 |
| A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects (NCT04742517) | Astellas Pharma Europe B.V. | 2017-11-20 |
| A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients (NCT03352765) | Memorial Sloan Kettering Cancer Center | 2017-11-20 |
| A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy (NCT03404791) | Janssen Research & Development, LLC | 2017-11-20 |
| Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis (NCT03516370) | Tatyasaheb Kore Dental College | 2017-11-20 |
| CAR-T Cell Immunotherapy for Advanced Lung Cancer (NCT03330834) | Sun Yat-sen University | 2017-11-20 |
| Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer (NCT03325816) | Georgetown University | 2017-11-20 |
| First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients (NCT03355196) | Novartis Pharmaceuticals | 2017-11-20 |
| Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas (NCT03311412) | Symphogen A/S | 2017-11-20 |
| Effect of Vitamin D Replacement on Bone Healing in Mini-dental Implants (NCT03356730) | Universidade de Passo Fundo | 2017-11-19 |
| Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis (NCT03334851) | Pfizer | 2017-11-17 |
| Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate (NCT03569345) | Merete Haedersdal | 2017-11-17 |
| This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam (NCT03325712) | Boehringer Ingelheim | 2017-11-17 |
| A Study of LY3375880 in Healthy Participants (NCT03343587) | Eli Lilly and Company | 2017-11-17 |
| A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors (NCT03343613) | Eli Lilly and Company | 2017-11-17 |
| Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) (NCT03303339) | Cardiff Oncology | 2017-11-17 |
| Feasibility and Efficacy of Portable Non-invasive Negative Pressure Ventilation in Fontan Patients (NCT03251742) | University Health Network, Toronto | 2017-11-17 |